ESTUDIO MULTICÉNTRICO, DOBLE CIEGO, ALEATORIZADO Y CONTROLADO CON PLACEBO PARA DETERMINAR EL EFECTO DE QVA149 SOBRE LA MEDIA DE LA FRECUENCIA CARDIACA DURANTE 24 HORAS, EN PACIENTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA (EPOC).
Datos básicos
- Protocolo:
- CQVA149A2203
- EUDRACT:
- 2007-003670-25
- NCT:
- Centro:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
NOVARTIS FARMACEUTICA, S.A.
Resultados del Ensayo Clínico
Antialarmins in Severe Asthma.
de Diego Damia, Alfredo, Martinez Valle, Ana Maria
Editorial Material. 10.1016/j.arbres.2023.09.008. 2023
Clinical Features and Outcomes Associated with Bronchial Asthma Among COVID-19 Hospitalized Patients.
Diaz, Miguel Angel; (...); De Diego, Alfredo
Article. 10.2147/JAA.S354082. 2022
Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough.
Domingo, Christian; (...); Puente-Maestu, Luis
Article. 10.1016/j.resinv.2024.08.005. 2024
Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study.
Davila, Ignacio; (...); Domingo, Christian
Article. 10.1007/s00408-023-00620-y. 2023
Erratum to 'Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough' [Respir Investig 62(6) (2024), 987-994].
Domingo, Christian; (...); Puente-Maestu, Luis
Correction. 10.1016/j.resinv.2024.12.004. 2024
Stress urinary incontinence in women with chronic cough: impact on coughrelated quality of life
Puente-Maestu, Luis; (...); Domingo-Ribas, Christian
Meeting Abstract. 10.1183/13993003.congress-2023.PA1924. 2023
The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro.
Milara, Javier; (...); Cortijo, Julio
Article. 10.1038/s41598-022-09241-6. 2022